Medicine Man Technologies Inc (SHWZ)
0.455
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Medicine Man Technologies Enterprise Value: 182.08M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 182.08M |
| May 30, 2024 | 181.98M |
| May 29, 2024 | 181.25M |
| May 28, 2024 | 182.28M |
| May 24, 2024 | 183.18M |
| May 23, 2024 | 185.58M |
| May 22, 2024 | 186.60M |
| May 21, 2024 | 187.38M |
| May 20, 2024 | 190.42M |
| May 17, 2024 | 186.43M |
| May 16, 2024 | 187.17M |
| May 15, 2024 | 186.39M |
| May 14, 2024 | 181.69M |
| May 13, 2024 | 189.40M |
| May 10, 2024 | 195.17M |
| May 09, 2024 | 190.31M |
| May 08, 2024 | 194.21M |
| May 07, 2024 | 193.44M |
| May 06, 2024 | 194.77M |
| May 03, 2024 | 195.01M |
| May 02, 2024 | 195.01M |
| May 01, 2024 | 197.36M |
| April 30, 2024 | 205.97M |
| April 29, 2024 | 197.36M |
| April 26, 2024 | 195.48M |
| Date | Value |
|---|---|
| April 25, 2024 | 197.65M |
| April 24, 2024 | 196.98M |
| April 23, 2024 | 199.71M |
| April 22, 2024 | 199.71M |
| April 19, 2024 | 199.71M |
| April 18, 2024 | 201.27M |
| April 17, 2024 | 202.05M |
| April 16, 2024 | 202.06M |
| April 15, 2024 | 208.32M |
| April 12, 2024 | 197.36M |
| April 11, 2024 | 201.27M |
| April 10, 2024 | 206.76M |
| April 09, 2024 | 206.77M |
| April 08, 2024 | 211.06M |
| April 05, 2024 | 213.02M |
| April 04, 2024 | 207.93M |
| April 03, 2024 | 205.97M |
| April 02, 2024 | 203.62M |
| April 01, 2024 | 206.95M |
| March 31, 2024 | 210.67M |
| March 28, 2024 | 200.67M |
| March 27, 2024 | 205.33M |
| March 26, 2024 | 205.53M |
| March 25, 2024 | 209.74M |
| March 22, 2024 | 211.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
37.49M
Minimum
Mar 20 2020
244.48M
Maximum
Feb 21 2024
128.62M
Average
132.44M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.05M |
| Revenue (Quarterly) | 41.60M |
| Total Expenses (Quarterly) | 44.31M |
| EPS Diluted (Quarterly) | -0.24 |
| Gross Profit Margin (Quarterly) | 43.11% |
| Profit Margin (Quarterly) | -38.59% |
| Earnings Yield | -186.8% |
| Normalized Earnings Yield | -192.58 |